Treatment Differences in Non-STEMI vs STEMI Patients
Author Information
Author(s): Rasoul Saman, Ottervanger Jan Paul, Dambrink Jan-Henk E, de Boer Menko-Jan, Hoorntje Jan CA, Gosselink AT Marcel, Zijlstra Felix, Suryapranata Harry, van't Hof Arnoud WJ
Primary Institution: Isala Klinieken, Dept of Cardiology, Zwolle, The Netherlands
Hypothesis
Are patients with non-ST elevation myocardial infarction undertreated?
Conclusion
Patients with non-STEMI have worse long-term mortality compared to STEMI, primarily due to differences in baseline characteristics and treatment.
Supporting Evidence
- 29% of patients had non-STEMI and 71% had STEMI.
- Long-term mortality was 20% in non-STEMI patients compared to 12% in STEMI patients.
- Non-STEMI patients received less aggressive treatment, including fewer instances of coronary angiography and revascularization.
Takeaway
This study found that people with a certain type of heart attack (non-STEMI) are often treated less aggressively than those with a different type (STEMI), which can lead to worse outcomes.
Methodology
Data from all patients with a discharge diagnosis of myocardial infarction from January 2001 to January 2002 were evaluated, with follow-up until December 2004.
Potential Biases
Potential selection bias due to not including all patients with myocardial infarction.
Limitations
Selection bias may affect the results, and the study reflects treatment and outcomes from 2001, which may not represent current practices.
Participant Demographics
Patients included were those diagnosed with myocardial infarction, with a higher proportion of non-STEMI patients being older and having more comorbidities.
Statistical Information
P-Value
0.006
Confidence Interval
95% CI not specified
Statistical Significance
p = 0.006
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website